CVS Health (CVS) has made an impressive comeback in 2025, with its stock soaring 45% so far this year. This sharp rebound ...

CVS CEO David Joyner just finished his first full quarter at the helm. He spoke with Yahoo Finance about the conservative ...

CVS Health reported $1.6 billion in profit for the fourth quarter, down from a $2 billion haul a year ago, according to its ...

CVS (CVS) CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more ...

CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...

The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...

Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...

Wall Street appears to like CVS (CVS) CEO David Joyner's conservative approach to the company's 2025 financial outlook, rewarding the stock with a nearly 15% bump by market close Wednesday.

CVS (CVS) CEO David Joyner has an ambitious plan to revamp the company's retail healthcare business and create a more integrated system of health professionals, which would change the way ...